Corcept Therapeutics

+$0.29 (+1.45%) As of 3:03 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CORT and other ETFs, options, and stocks.

About CORT

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol.

CEO
Joseph K. Belanoff
Employees
238
Headquarters
Menlo Park, California
Founded
1998

CORT Key Statistics

Market cap
2.15B
Price-Earnings ratio
21.84
Dividend yield
—
Average volume
833.62K
High today
$20.33
Low today
$19.90
Open price
$20.12
Volume
60.05K
52 Week high
$25.68
52 Week low
$15.83

CORT News

Simply Wall StMay 22

Gary Robb Is The Chief Business Officer & Secretary of Corcept Therapeutics Incorporated And They Just Sold 39% Of Their Shares - Simply Wall St

We wouldn't blame Corcept Therapeutics Incorporated ( ) shareholders if they were a little worried about the fact that Gary Robb, the Chief Business Officer & S

CORT Earnings

$0.00
$0.12
$0.23
$0.35
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure